Yan Chen

President & CEO at Elpis Biopharmaceuticals

Founder, President, and CEO. Yan brings more than 20 years of expertise in both mRNA display technology and biologic drug discovery in the oncology disease area. She was Biotherapeutics Discovery Head at Juno Therapeutics in Boston and Senior Vice President of Research at X-Body Biosciences which was acquired by Juno in 2015. Previously, she was an investigator and project leader in Oncology Biotherapeutics at Novartis Institutes for Biomedical Research. Earlier in her career, she was a scientist at Phylos and Adnexus playing instrumental roles in establishing the mRNA antibody and protein display technology platforms. Yan was a postdoctoral trainee in Immunology at Tufts Medical School and received her Ph.D. in Tumor Immunology from the National University of Singapore. She is the co-inventor of more than 20 antibody technologies and biologic therapeutics patents.

Timeline

  • President & CEO

    Current role

View in org chart